Business
– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Atox Bio, which develops therapeutics for severe infections, has...
Hi, what are you looking for?
– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Atox Bio, which develops therapeutics for severe infections, has...
– The company can market chair health-monitoring systems to hospitals and nursing homes in the US. – EarlySense, developer and marketer of a hospital...
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced that the Company has filed a citizen petition (CP) regarding the approvability of purported generic versions of...
– – Exoskeleton ReWalk Robotics has received the U.S. Food and Drug Administration approval for using its ReWalk device at home and in the community. ReWalk...
– Two California counties have filed a law suit against a number of pharmaceutical companies for allegedly promoting pain killer addiction. – California’s Orange...
– Synribo received provisional approval in 2012 subject to additional clinic trial data. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and Drug...
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...
Anne Wojcicki/ Getty – Last week Jewish Business News reported : on a battle that, California based, online genetic testing company 23andMe has found...
– – Internal incisions are tricky. Unlike exterior cuts, internal ones are constantly surrounded by fluids, a fact that renders many adhesives useless. When...
– The Affordable Care Act (“Obamacare”) represents the most systemic, transformative change in over 40 years to America’s largest economic sector: healthcare. This is...